Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products.
基於大麻素的藥品公司MediPharm Labs Corp.（tsx: LABS）（OTCQB：MEDIF）（FSE: MLZ）週四宣佈已與Remidose Aerosols Inc.達成許可協議，以獲得先進大麻產品的獨家權利。
Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors.
根據協議，包括加拿大患者平台和國際醫療分銷商在內的當前Remidose客戶將從2024年8月開始通過MediPharm進行服務。
MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.
MediPharm打算利用其現有的GMP基礎架構、客戶渠道和健康銷售專業知識來拓展這些先進產品在加拿大和國際市場的客戶群。
See also: Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
參見：大麻素藥品公司MediPharm的營收增長，CFO稱公司財務狀況強勁。
Learn more about innovation in cannabis at the upcoming Benzinga cannabis event. The 19th Benzinga Cannabis Capital Conference, returns to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
了解更多大麻創新，請參加即將到來的Benzinga大麻事件。第19屆Benzinga大麻資本會議將於10月8日至9日回歸芝加哥。立即通過此鏈接購買票。
The products in question are split into two main categories, including:
涉及的產品分爲兩大類，包括：
- Metered Dose Inhalers. Why? Used in the pharmaceutical industry as well, this inhalation format provides rapid onset without the adverse effects of smoking.
- Pressurized Sublingual Sprays. Why? Providing users with an accurate and repeatable experience, this aerosol delivery method has a faster onset, better bioavailability and a more pleasant taste and feel.
- 計量劑量吸入器。爲什麼？在製藥行業中也用於此，該吸入方式提供快速的起效作用，而不會產生吸菸的不良影響。
- 加壓舌下噴霧劑。爲什麼？提供用戶準確可重複的體驗，這種氣溶膠傳遞方式具有更快的起效作用，更好的生物利用度和更美妙的口感和體驗。
"MediPharm Labs is committed to providing access to non-smokeable, precision-dosed formats for cannabis patients and wellness consumers," David Pidduck, CEO of MediPharm said. "This agreement, in addition to bringing immediate revenue, opens many new potential global medical opportunities."
“MediPharm Labs致力於爲大麻患者和健康消費者提供非可吸菸，精密劑量格式，” MediPharm首席執行官David Pidduck說。“除了可帶來即時收入外，此次協議還爲全球許多新的潛在醫療機會打開了大門。”
MediPharm already has the requisite equipment and GMP facility for these product lines to be manufactured in-house with no material incremental capital costs.
MediPharm已經具備必備設備和GMP工廠，這些產品線可以在公司內部製造，不需要額外的資本成本。
Now read: This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
現在閱讀：此大麻素藥品公司看到2023年營收同比增長50％，減少虧損。
譯文內容由第三人軟體翻譯。